Neudle.com: alpha agonists

Differential
(Click to cross reference)

activated protein C resistance

acute intermittant porphyria

addiction, heroin

advances in neurology

adverse drug reaction

agitation

akathisia

alcohol

alcohol, neurologic complications with

alcoholic withdrawal states, DT's, convulsions, etc.

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

angiitis, granulomatous of CNS

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, posterior fossa

antiarrhythmic drugs

antibiotics

antibiotics, neurologic complications with

anticoagulant, complications of

anticoagulant, restarting

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

antidepressant

antimalarials

antioxidant

antiphospholipid antibodies

antithrombin III deficiency

arterial dissection, carotid

arterial dissection, multiple

arterial dissection, vertebral

arthralgia

arthritis

aspirin

atherosclerosis, premature

atrial myxoma

atrial septal aneurysm

attention deficit disorder with hyperactivity

autonomic dysfunction

axonal degeneration

Babinski sign

basal ganglia, infarction

basal ganglia, lesion of

behavior modification

behavioral disorder

benign sexual headache

benzodiazepine

beta adrenergic blocker

bevacizumab

blood dyscrasias, neurologic findings with

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

calcium antagonist

calcium antagonist, side effects of

cancer, cerebrovascular accident complicating patients with

cardiovascular disease

carotid angiogram

carotid artery atherosclerosis

carotid artery disease

carotid artery stenosis

carotid artery stenosis, intracranial

CAT scan, angiography

CAT scan, cord sign

CAT scan, hyperattenuation

CAT scan, venography

cavernous sinus, syndrome

cavernous sinus, thrombosis

central retinal artery occlusion

cerebellar hemorrhage

cerebellar infarction

cerebral edema

cerebral edema, origin and treatment

cerebral embolism

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral veins

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, atrial myxoma

cerebrovascular accident, complications with

cerebrovascular accident, cryptogenic

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, etiology

cerebrovascular accident, non atherosclerotic cause of

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, sex distribution

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, predisposed factor in

cerebrovascular disease, risk factors in

cerebrovascular disease, smoking in

cervical spine injury

cervical spine manipulation

chemosis

chest pain

Chiari Frommel syndrome

children

chiropractic manipulation

Clinical Pathologic Conference(C.P.C.)

collagen vascular disease

congenital birth defects

congenital malformation

congenital malformation, non CNS

congestive heart failure

constipation

controversies in neurology

coprolalia

corneal dystrophy

corpus callosum, infarction of

cortical vein thrombosis

cost effectiveness

coumarin

coumarin, restarting treatment

counselling

craniectomy, decompressive

delivery, complicated

developmental retardation

dextran

diabetes insipidus

diabetes mellitus

diabetes mellitus, chemical

diagnostic criteria

diet

differential diagnosis

difficulty climbing stairs

dilantin

disorientation

disseminated intravascular coagulation(DIC)

diurnal variation

dopamine agonist

dopamine antagonist

downward deviation of eyes

drowsiness

drug abuse

drug abuse, neurologic complications of

drug induced neurologic disorders

drug interactions

drug of choice

drug withdrawal

dural arteriovenous malformation

dural sinus thrombosis

Durett hemorrhages

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

epidemiology of neurology

erythropoietin treatment

evidence-based research

eye movement, painful

facial pain

facial weakness, bilateral

fibrinolytic agents, intra-venous local infusion

fibromuscular dysplasia

fine motor function, impaired

genetic neurologic disorders

Gilles de la Tourette syndrome

glucose tolerance test, abnormal

growth hormone

grunting

guanfacine

hallucination, auditory

hallucination, olfactory

headache, drug induced

headache, episodic

headache, progressive

headache, prophylaxis

headache, recurrent

headache, severe

headache, sudden onset of

headache, throbbing

headache, thunderclap

headache, treatment of

headache, unilateral

headache, vascular

headache, worst of life

hearing loss

hearing loss, sudden, unilateral

heart wall motion dysfunction

hematoma, intracerebral

hemianopia

hemoglobin abnormality, neurologic complications of

hemoglobinuria

hemolysis

heparin

heralding manifestation

hypercoagulable state

hypereosinophilic syndrome(HES)

hyperhidrosis

hyperhidrosis, unilateral

hypernephroma

hypersomnia

hypertension

hypertension, paroxysmal

hypocomplementemia

hyponatremia

hypoosmolality of serum

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

incidence

inclusion bodies

internal cerebral vein

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intracranial hypertension, benign

intracranial hypertension, benign, incidence of

intracranial pressure, increased

Korsakoff's psychosis

labor, complicated

lactic dehydrogenase(LDH)

lamotrigine

lateral sinus

lateral sinus thrombosis

L-dopa

L-dopa, drug interactions with and side effects of

LE cell preparation

learning disability, in children

lergotrile

level of consciousness, decreased

levonorgestrel

Lewy body

Lewy body disease, diffuse

lidocaine

lidocaine, intravenous

lifestyle

lithium

lumbar puncture, complications of

memory, disorder, treatment of

menopause

menses

menses, seizure with

mental status, abnormal

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

modafinil

monoamine oxidase inhibitors

monoclonal antibodies

mononeuropathy

mortality

movement disorder

movement disorder, drug induced

MRI, CAT scan compared to

MRI, contrast enhanced

multiple sclerosis, risk factors for

multiple system atrophy

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

myocardial infarction

neoplasm, pituitary, treatment of

neurocardiology

neuroleptic

neuroleptic, atypical

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic symptoms

neuromuscular blockade

neuropathology

neuropathology, brain

neuropathy

neuropathy, etiologies of

neuropathy, painful

neuropathy, peripheral, treatment

neuroprotective agents

neurotransmitter

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

obesity

obsessive-compulsive disorder

obstetric neurologic injuries

Ollier's disease(enchondromas, multiple)

opiate

optic atrophy

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, choreiform movements with

oral contraceptives, neurologic complications with

otitis, neurologic complications with

pain, management of chronic

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, etiology of

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, treatment of

Parkinsonism multiple-system atrophy

paroxysmal nocturnal hemoglobinuria

patent foramen ovale

pathology

patient information and support

pelvic deep venous thrombosis

pemoline

penicillamine

periarteritis nodosa

persistent eustacian valve

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pituitary, microadenoma

pizotifen

placebo effect

platelet inhibiting drugs

pleurisy

polyneuropathy

post herpetic neuralgia

posterior fossa

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

premonitory urges

prenatal diagnosis by amniocentesis

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

primary thrombocythemia

procainamide

progesterone

prognosis

progressive neurologic disorder

psychiatric problems in neurologic disorders

quadriparesis, progressive

remote effect of cancer on the nervous system

renal failure

restless leg syndrome

reversible cerebral vasoconstrictive syndromes

review article

rheumatic heart disease

rigidity

rimegepant

risk factors

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, diencephalic

seizure, non-treatment of

seizure, pregnancy

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sensorineural hearing loss

single photon emission computed tomography

skull x-ray

skull x-ray, abnormal

sleep

sleep pathology and physiology

smell

sniffing

somnolence

splenic-vein thrombosis

splenomegaly

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stillbirth

stimulant drugs

stimulation, deep brain

straight sinus

strokelike episodes

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

sumatriptan

superior petrosal sinus

superior sagittal sinus thrombosis

symmetric brain lesions

synucleinopathy

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, drug induced

tachycardia

Takotsubo cardiomyopathy

tamoxifen

tardive dyskinesia

temporal lobe, lesion

teratogenesis

teratogenic drugs

tetanus antitoxin

thalamus, infarction of

thalamus, lesion of

thalamus, lesion of-bilateral

tic, chronic multiple

tic, classification of

tissue plasminogen activator, intravenous

topiramate

transient ischemic attack

trauma

treatment of neurologic disorder

tremor

tricyclic antidepressant

trifluoperazine

trigeminovascular system

ultrasonography, head, fetus-neonate

undiagnosed

upgaze, paralysis of

urine osmolality, elevated

urokinase

vagus nerve stimulation

venous thrombosis, non-cerebral

vitamin supplementation

watershed infarcts

Watson-Schwartz reaction

weakness

weakness, generalized

weakness, progressive

workup

zonisamide

Showing articles 200 to 250 of 687 << Previous Next >>

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016

Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016

Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016

Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Eur J Cancer 54:139-148, Michot, JM,.,et al, 2016

Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer
J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016

Paraneoplastic Cerebellar Degeneration with Anti-Yo Antibodies - A Review
Ann Clin Trans Neurol 3:655-663, Venkatraman,A. & Opal,P., 2016

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Mystery Case: A 21-Year-Old Man with Visual Loss Following Marijuana Use
Neurol 84:e165-e169, Whitlock, J.B.,et al, 2015

Encephalitis and AMPA Receptor Antibodies
Neurol 84:2403-2412, Hoftberger, R.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Sarcoidosis
Adams & Victors Principles of Neurology, Chp 32, pg 721, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Treatment of Primary CNS Vasculitis with Rituximab: Case Report
Neurol 82:1287-1288, Salvarani, C.,et al, 2014

Triptans for Symptomatic Treatment of Migraine Headache
BMJ 348:g2285, Pringsheim, T. & Becker, W.J., 2014

Skin Nerve (-Synuclein Deposits
Neurol 82:1362-1369, Donadio, V.,et al, 2014

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014

Effect of Rituximab in Patients with Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy
JAMA Neurol 71:896-900, Irani, S.R.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

Apnea and Dysphagia as the Sole Features of an a-Synucleinopathy
Neurol 83:1988-1989, Gilhuis, H.J.,et al, 2014

Restless Genital Syndrome in Parkinson Disease
JAMA Neurol 71:1559-1561, Aquino, C.C.,et al, 2014

Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome
NEJM 370:621-631,667, Allen, R.P.,et al, 2014

Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Sarcoidosis Presenting as Longitudinally Extensive Myelitis
Neurol 81:e61, Goenka, N. & Venna N., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
JAMA Neurol 70:859-866, Savica, R.,et al, 2013

Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Tumor Necrosis Factor-Alpha Inhibitors: Risk of Malignancy
UpToDate January, Stone, J.H., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012

Evidence-based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults
Neurol 78:1337-1345, Silberstein,S.D.,et al, 2012

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

Showing articles 200 to 250 of 687 << Previous Next >>